| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology and Rehabilitation (Drs. Ainiala, Peltola, and Hietaharju), Tampere University Hospital; Department of Psychiatry (J. Loukkola), Pori Mental Health Centre; and the Department of Internal Medicine (Dr. Korpela), Division of Rheumatology, Tampere University Hospital, Finland.
Address correspondence and reprint requests to Dr. Hanna Ainiala, Department of Neurology and Rehabilitation, Tampere University Hospital, P.O. Box 2000, FIN- 33521 Tampere, Finland; e-mail: jukkaps{at}koti.soon.fi
Objective:— To describe the prevalence of neuropsychiatric (NP) syndromes in a Finnish population of patients with systemic lupus erythematosus (SLE) and to classify them according to the recently developed American College of Rheumatology (ACR) nomenclature and case definitions for NPSLE.
Methods:— Cross-sectional, population-based study covering an area with 440,000 people. A total of 58 patients with a definite diagnosis of SLE and aged 16 to 65 years were found in the computerized database of the area hospitals. Of these, 46 (79%) agreed to participate. The diagnosis of various NP syndromes was based on clinical impression (H.A.) following history, examination, review of medical records, and neuropsychologic testing.
Results:— At least one NP syndrome was identified in 42 patients (91%). The most frequent manifestation was cognitive dysfunction (n = 37; 81%), followed by headache (n = 25; 54%) and mood disorder (n = 20; 43%). When mild NP syndromes (mild cognitive deficit, headache, mild depression, anxiety, electroneuromyography-negative polyneuropathy) were excluded, the prevalence of NPSLE dropped to 46%.
Conclusions:— According to the ACR nomenclature, there is a high prevalence of NP manifestations in a population-based sample of patients with SLE. Most NP syndromes were classified as minor; if they were excluded, the 46% prevalence of NPSLE would be slightly less than estimated in previous studies.
This article has been cited by other articles:
|
|
 |
|
  A. O. Alao, S. Chlebowski, and C. Chung Neuropsychiatric Systemic Lupus Erythematosus Presenting as Bipolar I Disorder With Catatonic Features Psychosomatics, September 1, 2009; 50(5): 543 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Whitelaw and J. Spangenberg An investigation in the possible effect of chronic headache on neuropsychological function in aCL-negative patients with SLE Lupus, June 1, 2009; 18(7): 613 - 617. [Abstract] [PDF]
|
|
|
|
 |
|
 D Paran, I Litinsky, I Shapira-Lichter, S Navon, T Hendler, D Caspi, and E Vakil Impaired memory and learning abilities in patients with systemic lupus erythematosus as measured by the Rey Auditory Verbal Learning Test Ann Rheum Dis, June 1, 2009; 68(6): 812 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Y. Zhu, L.-S. Tam, V. W. Y. Lee, K. K. Lee, and E. K. Li Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong Rheumatology, May 1, 2009; 48(5): 564 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Pego-Reigosa and D. A. Isenberg Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease Rheumatology, October 1, 2008; 47(10): 1498 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sundquist, J. C. Martineus, X. Li, K. Hemminki, and J. Sundquist Concordant and discordant associations between rheumatoid arthritis, systemic lupus erythematosus and ankylosing spondylitis based on all hospitalizations in Sweden between 1973 and 2004 Rheumatology, August 1, 2008; 47(8): 1199 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sundquist, X. Li, K. Hemminki, and J. Sundquist Subsequent Risk of Hospitalization for Neuropsychiatric Disorders in Patients With Rheumatic Diseases: A Nationwide Study From Sweden Arch Gen Psychiatry, May 1, 2008; 65(5): 501 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhou, F. Zhang, X. Tian, X. Leng, J. Lu, Y. Zhao, F. Tang, X. Zhang, X. Zeng, Z. Zhang, et al. Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients Lupus, February 1, 2008; 17(2): 93 - 99. [Abstract] [PDF]
|
|
|
|
 |
|
 F. G. Joseph, G. A. Lammie, and N. J. Scolding CNS lupus: A study of 41 patients Neurology, August 14, 2007; 69(7): 644 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. J. Cha, K. Furie, J. Kay, R. P. Walensky, M. E. Mullins, and E. T. Hedley-Whyte Case 39-2006 -- A 24-Year-Old Woman with Systemic Lupus Erythematosus, Seizures, and Right Arm Weakness N. Engl. J. Med., December 21, 2006; 355(25): 2678 - 2689. [Full Text] [PDF]
|
|
|
|
|
|
M I Peralta-Ramirez, M A Coin-Mejias, J Jimenez-Alonso, N Ortego-Centeno, J L Callejas-Rubio, A Caracuel-Romero, and M Perez-Garcia Stress as a predictor of cognitive functioning in lupus Lupus, December 1, 2006; 15(12): 858 - 864. [Abstract] [PDF]
|
|
|
|
|
|
H I Brunner, A Bishnoi, A C Barron, L J Houk, A Ware, Y Farhey, A B Mongey, C F Strife, T B Graham, and M H Passo Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus Lupus, April 1, 2006; 15(4): 198 - 206. [Abstract] [PDF]
|
|
|
|
 |
|
 M.-T. Tseng, S.-C. Hsieh, C.-T. Shun, K.-L. Lee, C.-L. Pan, W.-M. Lin, Y.-H. Lin, C.-L. Yu, and S.-T. Hsieh Skin denervation and cutaneous vasculitis in systemic lupus erythematosus Brain, April 1, 2006; 129(4): 977 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Iikuni, H Okamoto, T Yoshio, E Sato, S Kamitsuji, T Iwamoto, S Momohara, A Taniguchi, H Yamanaka, S Minota, et al. Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus Ann Rheum Dis, February 1, 2006; 65(2): 253 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B I Glanz, P H Schur, R A Lew, and S Khoshbin Lateralized cognitive dysfunction in patients with systemic lupus erythematosus Lupus, November 1, 2005; 14(11): 896 - 902. [Abstract] [PDF]
|
|
|
|
|
|
E S Husebye, Z M Sthoeger, M Dayan, H Zinger, D Elbirt, M Levite, and E Mozes Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus Ann Rheum Dis, August 1, 2005; 64(8): 1210 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Y. McLaurin, S. L. Holliday, P. Williams, and R. L. Brey Predictors of cognitive dysfunction in patients with systemic lupus erythematosus Neurology, January 25, 2005; 64(2): 297 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Appenzeller, F. Cendes, and L. T.L. Costallat Epileptic seizures in systemic lupus erythematosus Neurology, November 23, 2004; 63(10): 1808 - 1812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Mitsikostas, P. P. Sfikakis, and P. J. Goadsby A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth Brain, May 1, 2004; 127(5): 1200 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O Nived, G Sturfelt, M H Liang, and P De Pablo The ACR nomenclature for CNS lupus revisited Lupus, December 1, 2003; 12(12): 872 - 876. [Abstract] [PDF]
|
|
|
|
|
|
S D Denburg and J A Denburg Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus Lupus, December 1, 2003; 12(12): 883 - 890. [Abstract] [PDF]
|
|
|
|
|
|
G Sanna, M L Bertolaccini, and A Mathieu Central nervous system lupus: a clinical approach to therapy Lupus, December 1, 2003; 12(12): 935 - 942. [Abstract] [PDF]
|
|
|
|
|
|
M Bodani and M D Kopelman A psychiatric perspective on the therapy of psychosis in systemic lupus erythematosus Lupus, December 1, 2003; 12(12): 947 - 949. [Abstract] [PDF]
|
|
|
|
|
|
S L Holliday, M G Navarrete, D Hermosillo-Romo, C R Valdez, A R Saklad, A Escalante, and R L Brey Validating a computerized neuropsychological test battery for mixed ethnic lupus patients Lupus, September 1, 2003; 12(9): 697 - 703. [Abstract] [PDF]
|
|
|
|
|
|
R. L. Brey and M. A. Petri Neuropsychiatric systemic lupus erythematosus: Miles to go before we sleep Neurology, July 8, 2003; 61(1): 9 - 10. [Full Text] [PDF]
|
|
|
|
|
|
A. Afeltra, P. Garzia, A. P. Mitterhofer, M. Vadacca, S. Galluzzo, F. Del Porto, L. Finamore, S. Pascucci, M. Gasparini, B. Lagana, et al. Neuropsychiatric lupus syndromes: Relationship with antiphospholipid antibodies Neurology, July 8, 2003; 61(1): 108 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Sanni and M. A Khamashta Low-dose pulse cyclophosphamide in the treatment of neuropsychiatric lupus Lupus, January 1, 2003; 12(1): 1 - 2. [PDF]
|
|
|
|
|
|
S. Malagold, I. Casas Parera, and H. Ainiala The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus Neurology, June 25, 2002; 58(12): 1867 - 1868. [Full Text] [PDF]
|
|
|
|
|
|
R. L. Brey, S. L. Holliday, A. R. Saklad, M. G. Navarrete, D. Hermosillo-Romo, C. L. Stallworth, C. R. Valdez, A. Escalante, I. del Rincon, G. Gronseth, et al. Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions Neurology, April 23, 2002; 58(8): 1214 - 1220. [Abstract] [Full Text] [PDF]
|
|
Read all Correspondence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
